OnCo
institutionsInstitution

Fox Chase Cancer Center

aka Fox Chase, Temple Health Fox Chase

Philadelphia's free-standing cancer centre, where the Philadelphia chromosome, the two-hit hypothesis and hepatitis B were discovered.

Formed in 1974 from the American Oncologic Hospital (1904) and the Institute for Cancer Research (1927), Fox Chase has held NCI comprehensive designation since 1974 and joined Temple University Health System in 2012. Its scientific record is exceptional: David Hungerford co-discovered the Philadelphia chromosome in 1960, Alfred Knudson proposed the two-hit hypothesis of tumour suppressor genes in 1971, Baruch Blumberg identified hepatitis B and developed its vaccine (Nobel Prize 1976), a cornerstone of liver cancer prevention, and Beatrice Mintz pioneered transgenic mice. Clinical strengths today include kidney and prostate cancer, hereditary cancer risk assessment and radiation oncology.

Location
Philadelphia, PA, US
Type
cancer center · Temple University
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#107 · 33 points (0 Newsweek + 15 NCI + 18 from 9 linked objects) · ranking

Programmes

3top
  • Kidney cancer
  • Hereditary cancer risk assessment
  • Radiation oncology

Connected

9top

Pages like this

not linked directly; found by shared links